Xylem Inc.
XYL · NYSE
12/31/2024 | 12/31/2023 | 12/31/2022 | 12/31/2021 | |
|---|---|---|---|---|
| Valuation | ||||
| PEG Ratio | 1.03 | 0.96 | -3.33 | 0.74 |
| FCF Yield | 3.35% | 2.28% | 1.95% | 1.53% |
| EV / EBITDA | 17.22 | 23.38 | 28.83 | 27.37 |
| Quality | ||||
| ROIC | 5.78% | 4.46% | 7.80% | 7.03% |
| Gross Margin | 37.51% | 36.90% | 37.74% | 38.02% |
| Cash Conversion Ratio | 1.42 | 1.37 | 1.68 | 1.26 |
| Growth | ||||
| Revenue 3-Year CAGR | 15.74% | 12.33% | 4.23% | -0.34% |
| Free Cash Flow Growth | 66.43% | 45.88% | 17.58% | -48.52% |
| Safety | ||||
| Net Debt / EBITDA | 0.59 | 1.22 | 1.38 | 1.39 |
| Interest Coverage | 22.93 | 13.31 | 12.44 | 7.70 |
| Efficiency | ||||
| Inventory Turnover | 5.37 | 4.56 | 4.30 | 4.60 |
| Cash Conversion Cycle | 70.42 | 84.07 | 80.51 | 73.87 |